We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$14.4B
AUM Growth
+$892M
Cap. Flow
-$156M
Cap. Flow %
-1.09%
Top 10 Hldgs %
18.69%
Holding
398
New
20
Increased
86
Reduced
202
Closed
16

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$105M
2
SMPL icon
Simply Good Foods
SMPL
+$78.2M
3
ACLS icon
Axcelis
ACLS
+$59.2M
4
MTDR icon
Matador Resources
MTDR
+$59M
5
DLB icon
Dolby
DLB
+$52M

Top Sells

Rank Stock Value
1
JLL icon
Jones Lang LaSalle
JLL
+$90.4M
2
TXRH icon
Texas Roadhouse
TXRH
+$64.4M
3
NTAP icon
NetApp
NTAP
+$55.3M
4
FIX icon
Comfort Systems
FIX
+$32.5M
5
SFM icon
Sprouts Farmers Market
SFM
+$31.1M

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Financials 14.98%
3 Healthcare 14.82%
4 Industrials 13.9%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
301
IBM
IBM
$211B
$730K 0.01%
3,302
HCA icon
302
HCA Healthcare
HCA
$87.2B
$719K 0.01%
1,768
VT icon
303
Vanguard Total World Stock ETF
VT
$77.1B
$670K ﹤0.01%
5,601
+1,376
+33% +$158K
TD icon
304
Toronto Dominion Bank
TD
$198B
$667K ﹤0.01%
10,550
SHW icon
305
Sherwin-Williams
SHW
$82.7B
$658K ﹤0.01%
1,724
CSX icon
306
CSX Corp
CSX
$93.4B
$645K ﹤0.01%
18,672
QUAL icon
307
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
$644K ﹤0.01%
3,590
NVO
308
Novo Nordisk
NVO
$208B
$639K ﹤0.01%
5,366
TRV icon
309
Travelers Companies
TRV
$78.1B
$605K ﹤0.01%
2,586
+533
+26% +$118K
WAB icon
310
Wabtec
WAB
$49.1B
$589K ﹤0.01%
3,241
MCHP icon
311
Microchip Technology
MCHP
$40.3B
$586K ﹤0.01%
7,300
UL icon
312
Unilever
UL
$137B
$583K ﹤0.01%
7,973
CRM icon
313
Salesforce
CRM
$151B
$558K ﹤0.01%
2,039
TT icon
314
Trane Technologies
TT
$100B
$542K ﹤0.01%
1,394
+15
+1% +$5.2K
CSL icon
315
Carlisle Companies
CSL
$14.3B
$540K ﹤0.01%
1,200
VEU icon
316
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$535K ﹤0.01%
8,491
GS icon
317
Goldman Sachs
GS
$300B
$528K ﹤0.01%
1,067
-397
-27% -$194K
BA icon
318
Boeing
BA
$171B
$491K ﹤0.01%
3,227
-203
-6% -$34.8K
CAT icon
319
Caterpillar
CAT
$375B
$483K ﹤0.01%
1,234
-300
-20% -$104K
AZN icon
320
AstraZeneca
AZN
$263B
$480K ﹤0.01%
3,083
+355
+13% +$57.3K
JEF icon
321
Jefferies Financial Group
JEF
$12.6B
$462K ﹤0.01%
7,500
XYL icon
322
Xylem
XYL
$27.3B
$462K ﹤0.01%
3,418
PLD icon
323
Prologis
PLD
$135B
$449K ﹤0.01%
3,558
VRTX icon
324
Vertex Pharmaceuticals
VRTX
$121B
$446K ﹤0.01%
960
-150
-14% -$72.1K
NOW icon
325
ServiceNow
NOW
$115B
$442K ﹤0.01%
2,470
-55
-2% -$9.04K

Similar funds

Boston Trust Walden's Q3 2024 Portfolio in Review

As of Q3 2024, Boston Trust Walden held 398 positions worth $14.4B, up 6.6% from $13.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q3 2024 filing shows 20 new, 86 increased, 202 reduced and 16 closed positions. Its largest new stake was Cullen/Frost Bankers: 958,038 shares worth $107M. The largest sale was Jones Lang LaSalle, an estimated $90.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q3 2024 buy was Cullen/Frost Bankers: 958,038 shares worth $107M.
  • Boston Trust Walden added most to Dolby in Q3 2024, an estimated $52M increase.
  • Boston Trust Walden's biggest Q3 2024 reduction was Jones Lang LaSalle, cutting an estimated $90.4M.
  • Boston Trust Walden fully exited Central Garden & Pet Co Class A in Q3 2024, selling an estimated $21.7M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $14.4B portfolio in Q3 2024.
  • Boston Trust Walden opened 20 new positions and closed 16 in Q3 2024.
  • Boston Trust Walden's portfolio value rose 6.6% quarter-over-quarter to $14.4B.

Based on Boston Trust Walden's 13F filing for Q3 2024, filed 24 Oct 2024.